Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,221.72. The company's market cap stands at 1.19T, with a P/E ratio of 42.09 and a dividend yield of 0.55%.
During the trading session on 2026-07-29, Eli Lilly(LLY) shares reached a daily high of $1,227.79 and a low of $1,211.01. At a current price of $1,221.72, the stock is +0.9% higher than the low and still -0.5% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 423.43K, versus its average volume of 2.23M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
...
Key Points Amgen wants a slice of the weight loss drug market. Its candidate for capturing that market share might not be up to the task. Its competitors are...
Key Points Eli Lilly currently displays stronger upward momentum in top-line growth, whereas Johnson & Johnson maintains a higher but flatter overall baseline....
Analyst ratings
81%
of 31 ratingsMore LLY News
Key Points One of Cathie Wood's funds just sold some AtaiBeckley shares. It also bought some Compass Pathways shares. This move makes total sense given that...
GH Research stock has surged 111.2% year to date, yet its valuation checks indicate the shares do not screen as a clear bargain. Investors are weighing that str...
Key Points Eli Lilly's newest acquisition will expand its neuroscience portfolio. The company is bracing for stiff competition within its core therapeutic are...
Wall Street investment bank Goldman Sachs (GS) is bucking consensus, forecasting weak sales of Eli Lilly’s (LLY) new weight-loss pill when the company reports e...
In July 2026, Illumina announced that its Billion Cell Atlas alliance, originally launched with AstraZeneca, Merck, and Eli Lilly, had expanded to include three...
Novo Nordisk’s lawsuit over obesity and diabetes drug advertising has pulled Eli Lilly (LLY) further into the spotlight and raised fresh questions about how thi...
GLP-1 drugs for weight loss are such a booming business that it was inevitable the major manufacturers of these wonder drugs would eventually end up in court. T...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.